Australia Pushes For More Drug Repurposing
Consultation Document Lays Out Regulatory And Legislative Options
Proposals on how to encourage more applications for new uses of repurposed drugs could see some significant changes, including an obligation on sponsors to file for new indications.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.